References
- Abul-Haj S. K., Martz D. G., Douglas W. F., Geppert L. J. Farber's disease. Report of a case with observations on its histogenesis and notes on the nature of the stored material. J. Pediat. 1962; 61: 221
- Azanza X. Une Nouvelle Neurolipidose. La Maladie de Farber. Editions Bergerel, Bordeaux 1969, Thesis
- Benyon J. H., Williams A. E. Mass and Abundance Tables for Use in Mass Spectrometry. Elsevier Publishing Company, Amsterdam, London, and New York 1963
- Bierman S. M., Edgington T., Newcomer V. D., Pearson C. M. Farber's disease: A disorder of mucopolysaccharide metabolism with articular respiratory and neurologic manifestations. Arthr. and Rheum. 1966; 9: 620
- Brady R. O. Cerebral lipidoses. Amer. Rev. Med. 1970; 21: 317
- Casparrini G., Horning E. C., Horning M. G. Gas phase analytical separation and structural study of ceramides. Chem. Phys. Lip. 1969; 3: 1
- Clausen J., Rampini S. Chemical studies of Farber's disease. Acta neurol. scand. 1970; 46: 313
- Crocker A. C., Cohen J., Farber S. The ‘lipogranulomatosis’ syndrome; Review, with report of patient showing milder involvement. Inborn Disorders of Sphingolipid Metabolism, S. M. Aronson, B. W. Volk. Pergamon Press Ltd., Oxford 1967; 485–503
- Farber S. A lipid metabolic disorder-disseminated ‘Lipogranulomatosis’ - a syndrome with similarity to and important difference from, Niemann-Pick and Hand-Schüller-Christian disease. Amer. J. Dis. Child. 1952; 84: 499
- Farber S., Cohen J., Uzman L. L. Lipogranulomatosis. A new lipo-glyco-protein ‘storage’ disease. J. Mt Sinai Hosp. 1957; 24: 816
- Folch J., Lees M., Sloane Stanley G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. biol. Chem. 1957; 226: 497
- Gatt S. Enzymatic aspects of sphingolipid degradation. Chemistry and Metabolism of Sphingolipids, C. C. Sweeley. North Holland Publishing Co., Amsterdam 1970; 235–249
- Hammarström S. Gas-liquid chromatography-mass spectrometry of synthetic ceramides containing phytosphingosine. J. Lipid Res. 1970; 11: 175
- Hammarström S., Samuelsson B., Samuelsson K. Gas-liquid chromatography-mass spectrometry of synthetic ceramides containing 2-hydroxy acids. J. Lipid Res. 1970; 11: 150
- Lauter C. J., Trams E. G. A spectrophotometric determination of sphingosine. J. Lipid Res. 1962; 3: 136
- Morell P., Constantino-Ceccarini E., Radin N. S. The biosynthesis by brain microsomes of cerebrosides containing nonhydroxy fatty acids. Arch. Biochem. 1970; 141: 738, And references therein
- Moser H. W., Prensky A. L., Wolfe H. J., Rosman N. P. Farber's lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside. Amer. J. Med. 1969; 47: 869
- Phillips G. B. The isolation and quantitation of the principle phospholipid components of human serum using chromatography on silicic acid. Biochim. biophys. Acta (Amst.) 1958; 29: 994
- Prensky A. L., Ferreira G., Carr S., Moser H. W. Ceramide and ganglioside accumulation in Farber's lipogranulomatosis. Proc. Soc. exp. Biol. (N. Y.) 1967; 126: 725
- Samuelsson B., Samuelsson K. Gas-liquid chromatographic separation of ceramides as di-O-trimethylsilyl ether derivatives. Biochim. biophys. Acta (Amst.) 1968; 164: 421
- Samuelsson B., Samuelsson K. Gas-liquid chromatography-mass spectrometry of synthetic ceramides. J. Lipid Res. 1969; 10: 41
- Samuelsson K. Identification and quantitative determination of ceramides in human plasma. Scand. J. clin. Lab. Invest. 1971; 27: 371
- Sribney M. Enzymatic synthesis of ceramide. Biochim. biophys. Acta (Amst.) 1966; 125: 542
- Stoffel W. Studies on the biosynthesis and degradation of sphingosine bases. Chemistry and Metabolism of Sphingolipids, C. C. Sweeley. North Holland Publishing Co., Amsterdam 1970; 139–158
- Vance D. E., Sweeley C. C. Quantitative determination of the neutral glycosyl ceramides in human blood. J. Lipid Res. 1967; 8: 621
- Zetterström R. Disseminated lipogranulomatosis (Farber's disease). Acta paediat. (Uppsala) 1958; 47: 501